USNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
USNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
Usana Health Sciences's adjusted revenue per share for the three months ended in Dec. 2023 was $11.484. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $53.22 for the trailing ten years ended in Dec. 2023.
During the past 12 months, Usana Health Sciences's average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.
During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Usana Health Sciences was 26.80% per year. The lowest was 11.50% per year. And the median was 15.25% per year.
As of today (2024-04-27), Usana Health Sciences's current stock price is $43.47. Usana Health Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $53.22. Usana Health Sciences's Cyclically Adjusted PS Ratio of today is 0.82.
During the past 13 years, the highest Cyclically Adjusted PS Ratio of Usana Health Sciences was 4.53. The lowest was 0.81. And the median was 2.36.
The historical data trend for Usana Health Sciences's Cyclically Adjusted Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted Revenue per Share | Get a 7-Day Free Trial | 50.08 | 51.43 | 52.34 | 53.10 | 53.22 |
For the Packaged Foods subindustry, Usana Health Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Cyclically Adjusted PS Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?
Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.
We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, Usana Health Sciences's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 11.484 | / | 129.4194 | * | 129.4194 | |
= | 11.484 |
Current CPI (Dec. 2023) = 129.4194.
Usana Health Sciences Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201403 | 6.336 | 99.695 | 8.225 |
201406 | 6.612 | 100.560 | 8.510 |
201409 | 7.236 | 100.428 | 9.325 |
201412 | 8.858 | 99.070 | 11.572 |
201503 | 8.383 | 99.621 | 10.890 |
201506 | 8.818 | 100.684 | 11.335 |
201509 | 8.759 | 100.392 | 11.292 |
201512 | 8.889 | 99.792 | 11.528 |
201603 | 9.548 | 100.470 | 12.299 |
201606 | 10.375 | 101.688 | 13.204 |
201609 | 10.148 | 101.861 | 12.894 |
201612 | 10.101 | 101.863 | 12.834 |
201703 | 10.223 | 102.862 | 12.862 |
201706 | 10.275 | 103.349 | 12.867 |
201709 | 10.646 | 104.136 | 13.231 |
201712 | 11.277 | 104.011 | 14.032 |
201803 | 12.030 | 105.290 | 14.787 |
201806 | 12.136 | 106.317 | 14.773 |
201809 | 11.870 | 106.507 | 14.424 |
201812 | 12.228 | 105.998 | 14.930 |
201903 | 11.409 | 107.251 | 13.767 |
201906 | 10.955 | 108.070 | 13.119 |
201909 | 11.726 | 108.329 | 14.009 |
201912 | 12.472 | 108.420 | 14.888 |
202003 | 12.372 | 108.902 | 14.703 |
202006 | 12.258 | 108.767 | 14.585 |
202009 | 14.101 | 109.815 | 16.618 |
202012 | 14.665 | 109.897 | 17.270 |
202103 | 14.599 | 111.754 | 16.907 |
202106 | 16.474 | 114.631 | 18.599 |
202109 | 13.611 | 115.734 | 15.220 |
202112 | 13.586 | 117.630 | 14.948 |
202203 | 14.007 | 121.301 | 14.944 |
202206 | 13.743 | 125.017 | 14.227 |
202209 | 12.118 | 125.227 | 12.524 |
202212 | 11.833 | 125.222 | 12.230 |
202303 | 12.850 | 127.348 | 13.059 |
202306 | 12.261 | 128.729 | 12.327 |
202309 | 11.014 | 129.860 | 10.977 |
202312 | 11.484 | 129.419 | 11.484 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.
For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Usana Health Sciences's Cyclically Adjusted PS Ratio of today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 43.47 | / | 53.22 | |
= | 0.82 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
During the past 13 years, the highest Cyclically Adjusted PS Ratio of Usana Health Sciences was 4.53. The lowest was 0.81. And the median was 2.36.
Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.
Thank you for viewing the detailed overview of Usana Health Sciences's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
John Turman Fleming | director | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Gilbert A Fuller | officer: CFO and Executive V.P. | 55 WANDERWOOD WAY, SANDY UT 84092 |
Frederic J Winssinger | director | 2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018 |
David Mulham Mulham | officer: Chief Field Development Office | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Paul A. Jones | officer: CFO | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Xia Ding | director | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Daniel A. Macuga | officer: Chief Communications Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Jim Brown | officer: Chief Production Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Brent Neidig | officer: CO & Man. Dir. of China | 3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120 |
J Scott Nixon | director | 757 EAST SOUTH TEMPLE, SUITE 150, SALT LAKE CITY UT 84102 |
Kevin Guest | officer: E.V.P. of Marketing | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Joshua Foukas | officer: Chief Legal Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120 |
G Doug Iiekking | officer: VP of Finance | C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Walter Noot | officer: Chief Information Officer | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Robert A Sinnott | officer: Chief Scientific Officer | 400 55 WATER STREET, VANCOUVER A1 V6B1A1 |
From GuruFocus
By PRNewswire PRNewswire • 06-01-2023
By PRNewswire • 10-18-2023
By GuruFocus Research • 10-24-2023
By PRNewswire • 10-02-2023
By PRNewswire • 08-16-2023
By PRNewswire • 12-20-2023
By PRNewswire • 12-04-2023
By PRNewswire • 08-01-2023
By PRNewswire • 09-06-2023
By PRNewswire • 01-03-2024